Y-Mabs Therapeutics, Inc.
Patents held now
No granted US patent is recorded under this name. The published applications below are what the record holds.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 1 abandoned · 1 no status recorded
Showing 1 to 7 of 7, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/421,157 | Use of ANTI-B7H3 Antibodies for Treating Cancer in the Central Nervous System | Jan 24, 2024 | Pending |
| 18/717,536 | scFv and Antibodies with Reduced Multimerisation | Dec 14, 2022 | Pending |
| 18/717,256 | Formulations Comprising a SADA Complex | Dec 14, 2022 | Pending |
| 18/008,581 | CD38 antibodies for the treatment of human diseases | Jun 14, 2021 | Pending |
| 17/924,161 | Anti-B7H3 Antibodies for the Treatment of Cancer | Jun 1, 2021 | Pending |
| 17/917,377 | Apr 21, 2021 | No status recorded | |
| 16/613,028 | Use of ANTI-B7H3 Antibodies for Treating Cancer in the Central Nervous System | May 14, 2018 | Abandoned |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built